These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36049557)

  • 21. Functional angiography-derived index of microcirculatory resistance validated with microvascular obstruction in cardiac magnetic resonance after STEMI.
    Shin D; Kim J; Choi KH; Dai N; Li Y; Lee SH; Joh HS; Kim HK; Kim SM; Ha SJ; Jang MJ; Park TK; Yang JH; Song YB; Hahn JY; Choi SH; Choe YH; Gwon HC; Lee JM
    Rev Esp Cardiol (Engl Ed); 2022 Oct; 75(10):786-796. PubMed ID: 35249841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and Predictive Value of Microvascular Flow Abnormalities after Successful Contemporary Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction.
    Aggarwal S; Xie F; High R; Pavlides G; Porter TR
    J Am Soc Echocardiogr; 2018 Jun; 31(6):674-682. PubMed ID: 29525249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of diabetes on the benefits from everolimus-eluting stent as compared to first-generation drug-eluting stent in patients with ST elevation myocardial infarction.
    De Luca G; Sauro R; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Palmieri V; Serino V; Rosato G; Suryapranata H; Di Lorenzo E
    Diab Vasc Dis Res; 2015 Sep; 12(5):306-14. PubMed ID: 26150193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distal protection device aggravated microvascular obstruction evaluated by cardiac MR after primary percutaneous intervention for ST-elevation myocardial infarction.
    Yoon CH; Chung WY; Suh JW; Cho YS; Youn TJ; Chun EJ; Choi SI; Chae IH; Choi DJ
    Int J Cardiol; 2013 Sep; 167(5):2002-7. PubMed ID: 22633663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients.
    Roguin A; Kandzari DE; Marcusohn E; Koolen JJ; Doros G; Massaro JM; Garcia-Garcia HM; Bennett J; Gharib EG; Cutlip DE; Waksman R
    Circ Cardiovasc Interv; 2018 Oct; 11(10):e007331. PubMed ID: 30354631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial.
    Pilgrim T; Heg D; Roffi M; Tüller D; Muller O; Vuilliomenet A; Cook S; Weilenmann D; Kaiser C; Jamshidi P; Fahrni T; Moschovitis A; Noble S; Eberli FR; Wenaweser P; Jüni P; Windecker S
    Lancet; 2014 Dec; 384(9960):2111-22. PubMed ID: 25189359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Worst lead ST deviation and resolution of ST elevation at one hour for prediction of myocardial salvage, infarct size, and microvascular obstruction in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Stensjøen AL; Hommerstad A; Halvorsen S; Arheden H; Engblom H; Erlinge D; Larsen AI; Sejersten Ripa M; Clemmensen P; Atar D; Hall TS
    Ann Noninvasive Electrocardiol; 2020 Nov; 25(6):e12784. PubMed ID: 32592427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
    Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
    JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing myocardial edema is associated with greater microvascular obstruction in ST-segment elevation myocardial infarction.
    Bonfig NL; Soukup CR; Shah AA; Olet S; Davidson SJ; Schmidt CW; Peterson R; Henry TD; Traverse JH
    Am J Physiol Heart Circ Physiol; 2022 Oct; 323(4):H818-H824. PubMed ID: 36083798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracoronary compared with intravenous bolus tirofiban on the microvascular obstruction in patients with STEMI undergoing PCI: a cardiac MR study.
    Ma Q; Ma Y; Wang X; Li S; Yu T; Duan W; Wu J; Wen Z; Jiao Y; Sun Z; Hou Y
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):1121-1132. PubMed ID: 32078096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium/Calmodulin-Dependent Protein Kinase II Delta Inhibition and Ventricular Remodeling After Myocardial Infarction: A Randomized Clinical Trial.
    Boyle AJ; Schultz C; Selvanayagam JB; Moir S; Kovacs R; Dib N; Zlotnick D; Al-Omary M; Sugito S; Selvarajah A; Collins N; McLachlan G
    JAMA Cardiol; 2021 Jul; 6(7):762-768. PubMed ID: 33851966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial.
    Lopes RD; de Barros E Silva PGM; de Andrade Jesuíno I; Santucci EV; Barbosa LM; Damiani LP; Nakagawa Santos RH; Laranjeira LN; Dall Orto FTC; Beraldo de Andrade P; de Castro Bienert IR; Alexander JH; Granger CB; Berwanger O
    JAMA Cardiol; 2018 Nov; 3(11):1113-1118. PubMed ID: 30264159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-ST-Segment-Elevation Myocardial Infarction Platelet Reactivity Is Associated With the Extent of Microvascular Obstruction and Infarct Size as Determined by Cardiac Magnetic Resonance Imaging.
    Massalha E; Oren D; Goitein O; Brodov Y; Fardman A; Younis A; Berkovitch A; Raibman-Spector S; Konen E; Maor E; Fefer P; Segev A; Beigel R; Matetzky S
    J Am Heart Assoc; 2022 Feb; 11(3):e020973. PubMed ID: 35043676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational Study.
    Ibrahim H; Sharma PK; Cohen DJ; Fonarow GC; Kaltenbach LA; Effron MB; Zettler ME; Peterson ED; Wang TY
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial.
    Nazir SA; Khan JN; Mahmoud IZ; Greenwood JP; Blackman DJ; Kunadian V; Been M; Abrams KR; Wilcox R; Adgey AA; McCann GP; Gershlick AH
    Trials; 2014 Sep; 15():371. PubMed ID: 25252600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magmaris Resorbable Magnesium Scaffold Versus Conventional Drug-Eluting Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity-Score-Matching Comparison.
    de Hemptinne Q; Xaplanteris P; Guédès A; Demeure F; Vandeloo B; Dugauquier C; Picard F; Warne DW; Pilgrim T; Iglesias JF; Bennett J
    Cardiovasc Revasc Med; 2022 Oct; 43():28-35. PubMed ID: 35641364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial.
    Iglesias JF; Muller O; Losdat S; Roffi M; Kurz DJ; Weilenmann D; Kaiser C; Heg D; Valgimigli M; Windecker S; Pilgrim T
    Int J Cardiol; 2021 Jul; 334():37-41. PubMed ID: 33887341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.
    Najjar SS; Rao SV; Melloni C; Raman SV; Povsic TJ; Melton L; Barsness GW; Prather K; Heitner JF; Kilaru R; Gruberg L; Hasselblad V; Greenbaum AB; Patel M; Kim RJ; Talan M; Ferrucci L; Longo DL; Lakatta EG; Harrington RA;
    JAMA; 2011 May; 305(18):1863-72. PubMed ID: 21558517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarction.
    McGeoch R; Watkins S; Berry C; Steedman T; Davie A; Byrne J; Hillis S; Lindsay M; Robb S; Dargie H; Oldroyd K
    JACC Cardiovasc Interv; 2010 Jul; 3(7):715-22. PubMed ID: 20650433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.